HETEROCYCLIC COMPOUND

Provided is a prophylactic or therapeutic agent for autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus), which has an excellent Tyk2 inhibition activity. The present...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YOSHIDA, MASATO, KUSUMOTO, TOMOKAZU, KIM, KWANG OK, LEE, GIL NAM, YOON, CHEOLHWAN, KANG, HYUN BIN, YOGO, TAKATOSHI, JEON, HYE SUN, MARUI, SHOGO, SETO, MASAKI, SUZUKI, HIDEO, ODA, TSUNEO, ISHICHI, YUJI, NAGAMIYA, HIROYUKI, RHIM, CHUL YUN
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided is a prophylactic or therapeutic agent for autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus), which has an excellent Tyk2 inhibition activity. The present invention relates to a compound represented by formula (I) [wherein each symbol is as defined in the description attached] or a salt thereof. L'invention concerne un agent prophylactique ou thérapeutique destiné à des maladies auto-immunes (par exemple le psoriasis, l'arthrite rhumatoïde, la maladie inflammatoire de l'intestin, le syndrome de Sjogren, la maladie de Behcet, la sclérose en plaques, le lupus érythémateux systémique), qui présente une excellente activité d'inhibition de Tyk2. La présente invention concerne un composé représenté à la formule (I) [dans laquelle chaque symbole est tel que défini dans la description ci-jointe] ou un sel de celui-ci.